0001140361-22-020572.txt : 20220525
0001140361-22-020572.hdr.sgml : 20220525
20220525161559
ACCESSION NUMBER: 0001140361-22-020572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220523
FILED AS OF DATE: 20220525
DATE AS OF CHANGE: 20220525
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wise John Drayton
CENTRAL INDEX KEY: 0001930805
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30739
FILM NUMBER: 22963089
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSMED Inc
CENTRAL INDEX KEY: 0001104506
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 541972729
STATE OF INCORPORATION: VA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 908-977-9900
MAIL ADDRESS:
STREET 1: 700 US HIGHWAY 202/206
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: INSMED INC
DATE OF NAME CHANGE: 20000128
4
1
form4.xml
FORM 4
X0306
4
2022-05-23
0001104506
INSMED Inc
INSM
0001930805
Wise John Drayton
700 US HIGHWAY 202/206
BRIDGEWATER
NJ
08807
true
Chief Commercial Officer
Common Stock
2022-05-23
4
A
0
26236
A
78137
D
Stock Option (right to buy)
20.01
2022-05-23
4
A
0
164580
0
A
2032-05-23
Common Stock
164580
164580
D
Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant, subject to Mr. Wise's continued employment with the Company on each vesting date.
Each Restricted Stock Unit was received as a grant on May 23, 2022, for no consideration.
In connection with the appointment of Mr. Wise as the Company's Chief Commercial Officer, the Company granted Mr. Wise an option to purchase a total of 164,580 shares of the Company's common stock under the Company's 2019 Incentive Plan. The option becomes exercisable based on the following vesting schedule: twenty-five percent (25%) vest on the first anniversary of the date of grant and twelve and one-half percent (12.5%) vest on each six month anniversary date thereafter through the fourth anniversary of the date of grant, subject to Mr. Wise's continued employment with the Company on each vesting date.
/s/ John Drayton Wise, by Michael Smith as Attorney-in-fact
2022-05-25